Related Experiment Videos
The endothelin system in septic and endotoxin shock
M Wanecek1, E Weitzberg, A Rudehill
1Department of Anaesthesiology and Intensive Care, Karolinska Hospital, S-171 76, Stockholm, Sweden. michael.wanecek@kirurgi.ki.se
European Journal of Pharmacology
|October 26, 2000
Summary
The endothelin system plays a direct role in septic and endotoxin shock pathophysiology, beyond just marking vascular injury. Research suggests endothelin receptor antagonists show promise for treating these critical conditions.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Immunology
Background:
- The endothelium's role has evolved from a passive barrier to an active participant in physiological processes.
- Endothelium-derived substances, including nitric oxide, prostaglandins, and endothelins, significantly influence circulation and responses to inflammation and trauma.
- The endothelin system, discovered in 1988, exhibits potent vasoconstrictor, immunomodulating, endocrinological, and neurological effects via multiple receptors.
Purpose of the Study:
- To systematically review findings on the endothelin system's involvement in septic and endotoxin shock.
- To highlight the endothelin system's role as a marker of vascular injury and a direct contributor to shock pathophysiology.
- To assess the potential of endothelin receptor antagonists in managing septic and endotoxin shock.
Main Methods:
- Systematic review of existing studies on the endothelin system in septic and endotoxin shock.
- Analysis of data from experimental endotoxemia models and clinical observations in septic shock.
- Evaluation of research on endothelin receptor antagonists in preclinical models.
Main Results:
- Septic shock and experimental endotoxemia involve significant cardiovascular changes, organ dysfunction, and microcirculatory disturbances.
- Elevated plasma endothelin levels are consistently observed in septic shock and endotoxemia.
- Endothelial dysfunction is implicated in the pathophysiology of septic and endotoxin shock, with endothelin system activation linked to complications like ARDS, cardiac dysfunction, and DIC.
Conclusions:
- The endothelin system is directly implicated in the pathophysiology of septic and endotoxin shock, not merely a marker of vascular injury.
- Animal studies using endothelin receptor antagonists have yielded promising results for potential therapeutic interventions.
- Further research is warranted to explore the clinical efficacy of endothelin receptor antagonists in human septic and endotoxin shock.